Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kytta-Balsam f
- Development stage
- Phase 3
- Lead developer
- Merck KGaA
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Kytta-Balsam f is a topical herbal and small molecule combination cream developed by Merck Selbstmedikation GmbH (now part of P&G Health). It contains a high concentration (35%) of comfrey root extract (*Symphytum officinale*) and 1.2% methyl nicotinate. The comfrey root extract provides anti-inflammatory and analgesic effects, primarily attributed to constituents such as allantoin and rosmarinic acid. Methyl nicotinate acts as a rubefacient, promoting local blood circulation and providing a warming sensation to alleviate muscle tension and rheumatic pain. It is indicated for the treatment of acute upper and lower back pain, as well as rheumatic complaints including muscle pain, joint discomfort, sciatica, and lumbago. Clinical data from a Phase III trial in Germany demonstrated its statistically significant superiority over both methyl nicotinate alone and placebo in reducing pain during movement.
- Brand names
- Kytta-Balsam f
- Other names
- Kytta-Balsam
02
Targets
HCAR2 (Hydroxycarboxylic acid receptor 2)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Kytta-Balsam f.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kytta-Balsam f.